Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Obalon Therapeutics Inc (OBLN_old)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Obalon Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Obalon Therapeutics historical data, for real-time data please try another search
3.050 0.000    0.00%
15/06 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 3.120 / 3.140
  • Day's Range: 2.948 - 4.800
Type:  Equity
Market:  United States
Obalon Therapeutics 3.050 0.000 0.00%

OBLN_old Balance Sheet

 
Assess the latest Obalon Therapeutics Inc balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced OBLN_old Annual Report data, financial summaries and charts are available for Obalon Therapeutics Inc investors with their own InvestingPro account.
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2021
31/03
2020
31/12
2020
30/09
2020
30/06
Total Current Assets 12.79 7.83 9.03 10.78
Cash and Short Term Investments 8.97 3.9 5.51 6.8
Cash - - - -
Cash & Equivalents 8.97 3.9 5.51 6.8
Short Term Investments - - - -
Total Receivables, Net 3.15 3.15 3.15 3.15
Accounts Receivables - Trade, Net - - - -
Total Inventory - - - -
Prepaid Expenses 0.49 0.6 0.19 0.64
Other Current Assets, Total 0.18 0.18 0.18 0.18
Total Assets 17.34 10.62 11.96 13.87
Property/Plant/Equipment, Total - Net 1.31 1.48 1.63 1.8
Property/Plant/Equipment, Total - Gross 3.98 4.08 4.16 4.26
Accumulated Depreciation, Total -2.67 -2.6 -2.53 -2.46
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 3.24 1.3 1.3 1.29
Other Assets, Total - - - -
Total Current Liabilities 6.86 5.05 5.05 5.6
Accounts Payable 0.58 0.61 0.66 1.05
Payable/Accrued - - - -
Accrued Expenses 5.85 4.43 4.33 4.42
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 0.43 - - -
Other Current liabilities, Total - - 0.06 0.12
Total Liabilities 7.25 5.95 6.04 6.7
Total Long Term Debt - 0.43 0.43 0.43
Long Term Debt - 0.43 0.43 0.43
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 0.38 0.48 0.56 0.67
Total Equity 10.1 4.67 5.92 7.18
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.01 0.01 0.01 0.01
Additional Paid-In Capital 199.02 189.42 189.35 189.05
Retained Earnings (Accumulated Deficit) -188.93 -184.76 -183.44 -181.88
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - - -
Total Liabilities & Shareholders' Equity 17.34 10.62 11.96 13.87
Total Common Shares Outstanding 3.34 2.59 2.59 2.58
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OBLN_old Price Commentary

Write your thoughts about Obalon Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Josh Taylor
Josh Taylor Jan 22, 2021 9:44
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Medium term forecast?
Josh Taylor
Josh Taylor Jan 22, 2021 9:44
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Medium term forecast?
Sunil Mishra
Sunil Mishra Jan 20, 2021 19:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Tomorrow Will it go up or down
Ralf Weber
Ralf Weber Jan 20, 2021 19:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i think down
Ralf Weber
Ralf Weber Jan 20, 2021 18:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I was about to buy last night, but did not at the end. STUPID, STUPID, STUPID
Gina Liddle
Gina Liddle Jan 20, 2021 17:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.nasdaq.com/articles/stock-alert%3A-obalon-therapeutics-surges-75-on-news-of-merger-with-reshape-lifesciences
Masuma Yeh
Masuma Yeh Jan 20, 2021 17:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats happening with this stock?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email